Jaguar Health (JAGX) EBT Margin (2015 - 2026)

Jaguar Health's (JAGX) quarterly EBT Margin came in at 43.03% in Q1 2026, up 52162.0% year-on-year from N/an in Q1 2025, and up 106.0% on a QoQ basis from 716.94% in Q4 2025.

Jaguar Health (JAGX) EBT Margin (2015 - 2026) Analysis & Trends

Jaguar Health (JAGX) has 12 years of EBT Margin data on file, last reported at 43.03% in Q1 2026.

  • On a quarterly basis, EBT Margin rose 52162.0% year-over-year to 43.03% in Q1 2026; TTM through Mar 2026 was 117.28%, a 23313.0% increase from a year earlier, with the FY2025 full-year figure at 469.09%, down 13330.0% from the prior year.
  • EBT Margin for Q1 2026 stood at 43.03%, up from 716.94% in the prior quarter.
  • Over the last five years, EBT Margin for JAGX reached as high as 43.03% in Q1 2026 and fell as low as 90820.0% in Q1 2022.
  • Historically, EBT Margin has averaged 8773.98% across 5 years, with a median of 398.47% in 2024.
  • Across the five-year window, EBT Margin tumbled 8982588 bps in 2022 and soared 6327111 bps in 2023, its largest moves.
  • Year by year, EBT Margin stood at 25725.0% in 2022, then soared by 98 bps to 404.74% in 2023, then climbed by 28 bps to 291.65% in 2024, then slumped by 146 bps to 716.94% in 2025, then surged by 106 bps to 43.03% in 2026.
  • Per Business Quant data, the three most recent EBT Margin figures were 43.03% in Q1 2026, 716.94% in Q4 2025, and 312.94% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Nanobiotix 1,782.24 Bn 1,782.18 Bn - -
2 Akari Therapeutics 1,009.43 Bn 1,009.43 Bn - -
3 BeOne Medicines 473.46 Bn 468.66 Bn 1.35 Bn 17.13%
4 Vertex Pharmaceuticals 123.84 Bn 116.59 Bn 2.59 Bn 41.95%
5 Regeneron Pharmaceuticals 71.69 Bn 62.94 Bn 3.31 Bn 23.05%
6 Belite Bio 62.15 Bn 62.15 Bn - -
7 Argenx Se 54.74 Bn 49.55 Bn 1.41 Bn 34.77%
8 Alnylam Pharmaceuticals 38.08 Bn 35.07 Bn 959.66 Mn 18.99%
9 Revolution Medicines 36.07 Bn 36.07 Bn - -
10 Jaguar Health 520,945.88 -9.54 Mn 19.11 Mn 43.03%

Historic Data

Download Data
DateValue
Mar 31, 2026 43.03%
Dec 31, 2025 -716.94%
Sep 30, 2025 -312.94%
Jun 30, 2025 -354.48%
Mar 31, 2025 -478.59%
Dec 31, 2024 -291.65%
Sep 30, 2024 -322.43%
Jun 30, 2024 -353.84%
Mar 31, 2024 -398.47%
Dec 31, 2023 -404.74%
Sep 30, 2023 -280.98%
Jun 30, 2023 -467.87%
Mar 31, 2023 -27,548.89%
Dec 31, 2022 -25,725.00%
Sep 30, 2022 -402.46%
Jun 30, 2022 -321.47%
Mar 31, 2022 -90,820.00%
Dec 31, 2021 -688.37%
Sep 30, 2021 -1,982.44%
Jun 30, 2021 -3,715.30%